Experimental Cancer Vaccine Shows Promise in Late-Stage Trial
New york: Merck and Moderna’s experimental personalized cancer vaccine has delivered positive results in its first phase three trial, the companies announced Wednesday, moving the treatment closer to potential regulatory approval.
According to Anado…